DIRS.INFO The most relevant business & tech news

☆ Ro, the $7 billion healthcare startup, has a high-stakes strategy to take off-brand Ozempic mainstream
▼ + stars: | 2024-02-07 | by ( ) www.businessinsider.com time to read: +11 min

The $7 billion healthcare startup Ro, which has been prescribing brand-name weight-loss shots since January 2023, now offers compounded semaglutide to patients enrolled in its weight-management program. Nonetheless, Ro is the first prominent healthcare company to effectively endorse compounded semaglutide by prescribing it. A poor-quality compounded drug might simply be a dud and a waste of money. But while compounding pharmacies are subject to FDA and state regulations, states are the main regulators, and their oversight is patchy. Michael Siluk/UCG/Universal Images Group via Getty ImagesIt's hard to know if any given vial of compounded semaglutide is safe.

Persons: Wegovy's, Ro, drugmakers, Eli Lilly's, Eli Lilly's Mounjaro, Scott Gottlieb, Michael Siluk, That's, they've, Ozempic, Eli Lilly, Eric Kastango, they're, Kastango, aren't, Al Carter, Sarah Jones Simmer, Spencer Nadolsky, WeightWatchers, Tim Church, Wondr, it's, hasn't Organizations: Business, Novo Nordisk's Wegovy, US Food and Drug Administration, FDA, Novo Nordisk's Ozempic, Getty, Novo Nordisk, USP, National Association of, Pharmacy, Health Locations: Novo, Massachusetts, Austria, New York City

☆ Three stocks stocks that could replace Tesla in the Magnificent 7
▼ + stars: | 2024-02-07 | by ( Yun Li | ) www.cnbc.com time to read: +2 min

Now some on Wall Street believe Tesla no longer deserves to be among the coveted " Magnificent 7 ," and are suggesting alternatives that could replace Elon Musk's company. "The Magnificent 7 now looks more like the Magnificent 6 as Tesla falls from the crowd," billionaire investor Leon Cooperman , CEO of the Omega Family Office, said on CNBC's " Squawk Box " Tuesday. Meanwhile, there are now 29 companies that contributed more to S & P 500 earnings than Tesla, according to Strategas Securities. The research firm identified three companies with both market cap weighting and earnings contributions (for the next 12 months) larger than Tesla — Berkshire Hathaway , Broadcom and Eli Lilly . "Berkshire spent last year fliting with the top seven, but Broadcom and Lilly have steadily gained share," Strategas said in a note.

Persons: Tesla, Elon, Leon Cooperman, Berkshire, Eli Lilly, Lilly, Strategas, Warren, Eli Lilly's, — CNBC's Michael Bloom Organizations: Elon Musk's, Omega, Strategas Securities, Berkshire Hathaway, Broadcom, Berkshire, JPMorgan Locations: Warren Buffett's Berkshire

Others are calling for larger foundations to help grantees if they are sued or are offering legal assistance themselves. The Council on Foundations, which supports philanthropic foundations and provides legal resources to its members to help them consider potential legal risks, submitted an amicus brief in the case supporting the Fearless Fund's First Amendment argument. “If you’re committed to DEI or race-conscious or race-based giving, you should not back down on your priorities. We’re funding homelessness or employment or the wealth gap,” she said as examples of changes in wording funders have made. The Black Freedom Fund, which was founded in 2021 to fund Black community organizations in California, has started a legal defense fund for its grantees for precisely that reason.

Persons: aren't, Fearless, Edward Blum, Blum, —, Searle, Sarah Scaife, Kathleen Enright, you’re, ”, John Palfrey, John D, Catherine T, Claudine Gay, Christopher Rufo, Bill Ackman, Gay, MacArthur, “, Mae Hong, Carmen Rojas, Marguerite Casey, Rojas, can’t, ” Rojas, Marc Philpart, ” Philpart, Hong, they’re, ” Hong Organizations: —, American Alliance for Equal Rights, Fair, Searle Freedom Trust, Sarah Scaife Foundation, Fidelity Investments, Donors Trust, National Philanthropic Trust, Foundations, MacArthur Foundation, Harvard University, Manhattan Institute, Harvard, Rockefeller Philanthropy Advisors, Blacks, Marguerite Casey Foundation, Freedom Fund, “, Lilly Endowment Inc, AP Locations: Black, California

☆ The decline in Eli Lilly can be attributed to 'authentic stupidity', says Jim Cramer
▼ + stars: | 2024-02-07 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe decline in Eli Lilly can be attributed to 'authentic stupidity', says Jim Cramer'Mad Money' host Jim Cramer talks Eli Lilly, Apple, and action in the markets that doesn't make sense.

Persons: Eli Lilly, Jim Cramer, Apple

The settlement is likely to benefit as many as 500,000 residents whether they have insurance or not, and it covers all Lilly brand-name insulin products, Ellison said at a news conference. Litigation remains pending against two other manufacturers named in the 2018 lawsuit, Sanofi-Aventis and Novo Nordisk. The American Diabetes Association says more than 8 million Americans use insulin, which the body needs to convert food into energy. President Joe Biden's 2022 Inflation Reduction Act capped out-of-pocket costs of insulin to people on Medicare to $35 a month, but only for seniors. Novo Nordisk last year also announced plans for insulin price cuts starting this year.

Persons: Eli Lilly, Lilly, Keith Ellison, Ellison, ” Ellison, Joe Biden's, Alec Smith, Nicole Smith, Holt, ” Organizations: PAUL, —, Sanofi, Aventis, Novo Nordisk, American Diabetes Association, York, Medicare Locations: — Minnesota, Minnesota, California , Illinois, Arizona, Utah

☆ Wall Street gives 2 of our healthcare stocks well-deserved price target bumps
▼ + stars: | 2024-02-07 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +6 min

Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round of well-deserved price target bumps for the Club stocks. GE Healthcare fell slightly Wednesday, holding on to most of Tuesday's almost 11.7% surge. The biggest price target boost for GE Healthcare came from Piper Sandler, going to $94 per share from $84 while reiterating its buy-equivalent rating. Goldman Sachs, which has a hold rating on Eli Lilly, bumped its price target to $650 a share from $600. The GE Healthcare scanner is called the Revolution CT. Martin Schutt | picture alliance | Getty Images

Persons: Eli Lilly, tirzepatide, Lilly, it's, Piper Sandler, —, Mizuho, Wells Fargo, Evercore, Eli Lilly's, Lilly's, Eli, Truist, Cantor Fitzgerald, Morgan Stanley, Goldman Sachs, Jim Cramer's, Jim Cramer, Jim, Martin Schutt Organizations: GE Healthcare, Club, GE, Mizuho Securities, Electric, BMO Capital Markets, Truist Securities, CNBC, Bank of America, Barclays, Getty Locations: Amgen, China, Eli Lilly's, Wells Fargo, Jena , Germany

☆ Cramer says Palo Alto is a buy, plus what we want from Disney and Wynn earnings
▼ + stars: | 2024-02-07 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Jim Cramer said he sees two reasons for the turnaround: "First off, the positive results from its NASH study are bigger than we think. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. A liquid hydrogen tanker truck taking a fuel delivery at the Linde hydrogen plant in Leuna, Germany, on Tuesday, July 14, 2020.

Persons: Jim Cramer, let's, Eli Lilly, NASH, Amgen, Lilly, Linde, We've, Cramer, DuPont, Estee Lauder, Jim Cramer's, Jim, Rolf Schulten Organizations: CNBC, Nasdaq, Air Products, DuPont, Tech, Alto Networks, Disney, Wynn Resorts, Fox, Warner Bros, Netflix, PayPal, Arm Holdings, Jim Cramer's Charitable, Linde, Bloomberg, Getty Locations: We're, U.S, cybersecurity, Macao, Vegas, Leuna, Germany

☆ Wednesday analyst calls: JPMorgan downgrades New York Community Bancorp, Eli Lilly gets big boost
▼ + stars: | 2024-02-07 | by ( Pia Singh | ) www.cnbc.com time to read: +8 min

Troubled regional bank New York Community Bank faced a downgrade from JPMorgan, which said NYCB is facing a multitude of challenges. The firm upped its price target for the drug maker to $850, all the way from $200. Wells Fargo : Analyst Zachary Fadem kept his overweight rating and raised his target price by $200 to $2,800, implying 12.5% upside for shares. "After speaking to management, we confirmed these two executives had indeed left the company, wrote JPMorgan analyst Steven Alexopoulos. NXP's stock price is down 2.9% for the year, but still higher than 15% over the past 12 months.

Persons: Eli Lilly, Eric Gonzalez, Gonzalez, Wells, Zachary Fadem, Sara Senatore, Chipotle, — Pia Singh, JPMorgan downgrades, Steven Alexopoulos, Alexopoulos, John Melloy, Vivek Arya, Arya, Robyn Karnauskas, Karnauskas, Zepbound Organizations: CNBC, New York Community Bank, JPMorgan, Pharma, Truist Securities, Semiconductors, Bank of America, KeyBanc, Barclays, New York Community Bank JPMorgan, New, Community Bank, Financial Times, Bloomberg News, New York Community Bancorp, Battery Management Systems, Food and Drug Administration Locations: Wells Fargo, Tuesday's

☆ John Goodman wants a do-over in his favorite Coen Brothers movie
▼ + stars: | 2024-02-07 | by ( Jason Guerrasio | ) www.businessinsider.com time to read: +8 min

When you think of John Goodman, you likely picture him as Walter Sobchak, the gun-toting bowling enthusiast from "The Big Lebowski." For the latest installment in BI's "Role Play" series, Goodman discusses his favorite Coen brothers movie, why "Bringing Out the Dead" was a hard movie to make, and the time he called 411 looking for Al Pacino. On his favorite Coen Brothers movie and faking it in his first movie roleYou made your movie debut in 1983 in "Eddie Macon's Run," which stars Kirk Douglas. [Laughs]On working with Al Pacino and the casting rumor about him he's never heard(L-R) John Goodman and Al Pacino in "The Sea of Love." [Laughs]On the movie that felt like he 'wasted a great opportunity'(L-R) John Goodman and Nicolas Cage in "Bringing Out the Dead."

Persons: John Goodman, Walter Sobchak, Dan Conner, Roseanne, Sulley, Rosanne, Goodman, Eli Gemstone, He'll, I've, I'm, Dan, Rosanne Barr, Barr, Coen, Al Pacino, Eddie Macon's, Kirk Douglas, Douglas, Kirk, Barton Fink, It's, Rushmore, Jeff, he's, Uncle Buck, John, Candy, Alfredo Pacino, Pacino, You've, Nicolas Cage, Martin Scorsese's, Dan Aykroyd, Scorsese, He's, he'd, Babe Ruth, Turturro, Eugene O'Neill Organizations: Inc, ABC, Al, Denzel Locations: televangelists, Angeles, Charleston, Laredo , Texas, Denzel Washington, Manhattan

☆ Jim Cramer says recent moves in Apple, Chipotle and Eli Lilly shares don't make sense
▼ + stars: | 2024-02-07 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer on Wednesday reminded investors that not all market moves are sensible, pointing to recent actions that he believes reflect faulty reasoning. To Cramer, Wall Street's treatment of Apple stock hasn't been wise. Cramer has long thought investors should own Apple, and said saw the value of the new virtual reality product before its official release. But Eli Lilly 's action has especially puzzled Cramer. The pharmaceutical giant announced on Tuesday its popular drug for weight loss and diabetes may also treat liver ailments.

Persons: CNBC's Jim Cramer, Cramer, Wall, Eli Lilly Organizations: Apple, Starbucks Locations: U.S

Still, Eli Lilly and Novo Nordisk appear to be making some encouraging progress. Eli Lilly wasn't the only weight loss drug producer to see positive supply developments in the last week. Novo Holdings, which owns almost 77% of the voting shares in Novo Nordisk, said Monday it will acquire drug manufacturer Catalent in a $16.5 billion deal. Novo Nordisk will then buy three of Catalent's manufacturing plants from Novo Holdings for $11 billion. Tema in November launched an ETF whose key holdings include companies benefiting from the hype around weight loss drugs.

Persons: Eli Lilly, Anat Ashkenazi, Incretin, Eli Lilly's, Ashkenazi, Eli Lilly wasn't, Yuri Khodjamirian, Danish drugmaker Organizations: Novo Nordisk, Holdings, Wegovy, Novo Holdings, CNBC, Tema, Nordisk, Reuters Locations: North Carolina, Novo, Tema, Brussels, Danish, U.S

☆ Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue
▼ + stars: | 2024-02-06 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. Eli Lilly on Tuesday reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes drug, Mounjaro. Zepbound, which won approval from U.S. regulators in early November, raked in $175.8 million in sales for the fourth quarter. Shares of Eli Lilly were up 5% in premarket trading Tuesday. With a market cap of roughly $673 billion, Eli Lilly is the largest pharmaceutical company based in the U.S.Eli Lilly will hold an earnings call with investors at 10:00 a.m.

Persons: Eli Lilly, Eli Lilly's, Mounjaro Organizations: LSEG, FactSet Locations: San Diego , California, U.S

☆ GEHC stock finally gets some respect after earnings. Those betting against it got slammed
▼ + stars: | 2024-02-06 | by ( Jeff Marks | ) www.cnbc.com time to read: +8 min

Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. The quarterly earnings result from GE Healthcare on Tuesday is the best of both worlds. Quarterly commentary In addition to the mid-single-digit organic revenue growth, total company orders increased by 3%. The continued divergence in orders between the two companies suggests GE HealthCare is taking market share in the industry. A GE Healthcare Ltd. BioProcess machine stands on display during the International Pharmaceutical Expo (Interphex) in New York.

Persons: Eli Lilly, GEHC, It's, Jim Cramer, Philips, we're, GEHC's, We're, Jim Cramer's, Jim Organizations: GE Healthcare Technologies, The, Starbucks, GE Healthcare, General Electric, GE HealthCare, Management, JPMorgan Healthcare, Federal Reserve, CNBC, GE Healthcare Ltd, International Pharmaceutical, Bloomberg, Getty Locations: China, ultrasounds, MRIs, New York

☆ Wall Street says Big Tech needs to take a breather after huge run. Here's our take
▼ + stars: | 2024-02-06 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. "This is a consolidation day," Jim Cramer said Tuesday. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Eli Lilly, We're, Jim, We're bullish, Jim Cramer's Organizations: CNBC, Big Tech, Citigroup, GE Healthcare

☆ Three-Stock Lunch: Eli Lilly, Spotify and Chipotle
▼ + stars: | 2024-02-06 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree-Stock Lunch: Eli Lilly, Spotify and ChipotleCourtney Garcia, Payne Capital Management senior wealth advisor, joins 'Power Lunch' to discuss three stocks: Eli Lilly, Spotify and Chipotle.

Persons: Eli Lilly, Chipotle Courtney Garcia Organizations: Payne Capital Management

☆ Stocks making the biggest moves premarket: Spotify, Eli Lilly, Palantir, UBS and more
▼ + stars: | 2024-02-06 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

The compan y posted adjusted earnings of $2.49 per share on revenue of $9.35 billion. Analysts anticipated $2.22 per share on revenue of $8.93 billion, according to LSEG. The company's revenue of $3.42 billion also beat analysts' forecasts of $3.40 billion. Chegg expects revenue between $173 million to $175 million, lighter than the $180.1 million consensus estimate, per StreetAccount. UPS -- Shares of the delivery company rose more than 1% after UBS upgraded the stock to buy from neutral.

Persons: Eli Lilly, Tesla, Li, amortization, Rambus, Macheel, Jesse Pound, Sarah Min, Michelle Fox Theobald Organizations: Spotify, LSEG, UBS —, JPMorgan, UBS, BP, Deutsche Bank, StreetAccount, UPS Locations: Swiss, StreetAccount .

NEW YORK (AP) — Even as Catholic dogma continues to repudiate same-sex marriage and gender transition, one of the most prominent religious orders in the United States — the Jesuits — is strengthening a unique outreach program for LGBTQ+ Catholics. James Martin, a Jesuit who is one of the country's most prominent advocates for greater LGBTQ+ inclusion in the Catholic Church. On Tuesday, there was another milestone for Outreach — the appointment of journalist and author Michael O'Loughlin as its first executive director. The latest expansion of Outreach occurs amid a time of division within the global Catholic Church as it grapples with LGBTQ+ issues. “It’s a special grace for LGBTQ Catholics to know that the pope is praying for them," Martin said.

Persons: James Martin, Michael O'Loughlin, O'Loughlin, “, they’re, ” O'Loughlin, Pope Francis, Martin, ” Martin, “ Pope Francis, Brian Paulson, Jesus, ” Paulson, Martin's, ”, Cardinal Timothy Dolan, Tania Tetlow, Archbishop John Wester Organizations: Jesuit, Catholic Church . Outreach, America, Associated Press, Vatican, Outreach, Jesuit Conference of Canada, Fordham University, Church, Lilly Endowment Inc, AP Locations: United States, New York City, America, U.S, Africa, Europe, Ireland, New York, Santa Fe , New Mexico

NEW YORK (AP) — GoFundMe crowdfunding campaigns have generated $30 billion since 2010, the fundraising platform announced Tuesday, as younger generations look beyond institutions to make their donations. GoFundMe, a privately held, for-profit company, has annually released the total amount raised on its crowdfunding platform since its founding, but hasn't published a breakdown of funds raised in an individual year. Part of that growth includes GoFundMe's acquisition of Classy in 2022, which is an online platform that facilitates giving to nonprofit organizations. It's not yet clear how much giving through a crowdfunding campaign has supplanted giving to nonprofit organizations, Soskis said, in part because data about crowdfunding is less public. Other platforms also facilitate online crowdfunding, besides GoFundMe.

Persons: GoFundMe, Tim Cadogan, GoFundMe's, Gen, Indiana University Lilly, “, we’ve, ” Cadogan, hasn't, Cadogan, “ That’s, Damar, ’ ”, Margaret Richardson, Hamlin, —, Benjamin Soskis, It's, Soskis, ” Soskis, it's, Meta, ” Organizations: Indiana University, Indiana University Lilly Family School of Philanthropy, Associated Press, Buffalo Bills, Corporate, Hamlin, M’s, Urban Institute, Nonprofit, IRS, Facebook, Associated, Lilly Endowment Inc, AP Locations: U.S, Uvalde , Texas, ecommerce, GoFundMe

☆ Seaport Research says a correction is here: 'The market is too narrow and policy is too tight'
▼ + stars: | 2024-02-06 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

"The market is too narrow and policy is too tight," Seaport macro strategist Victor Cossel wrote Tuesday. Cossel said the current market breadth for the S & P 500 , the Nasdaq 100 and the Russell 2000 is rolling over into the new year. Stocks have slipped to start the week after both the S & P 500 and Dow Jones Industrial Average closed at fresh record highs Friday . Tech stocks have led the charge that has driven the overall market higher, boosted by earnings results from Amazon and Facebook parent Meta Platforms . But the outperformance of tech stocks may come at a price to the broader market, Cossel said.

Persons: Victor Cossel, Cossel, Russell, Eli Lilly, Jerome Powell, — CNBC's Michael Bloom Organizations: Seaport Research Partners, Nasdaq, Federal, Dow Jones, Tech, Amazon, Facebook, Nvidia, Meta, Microsoft

☆ BofA's Geoff Meacham on Eli Lilly on Q4 results: The story has changed to diabetes and obesity
▼ + stars: | 2024-02-06 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBofA's Geoff Meacham on Eli Lilly on Q4 results: The story has changed to diabetes and obesityGeoff Meacham, Bank of America Securities senior pharmaceuticals analyst, joins 'Squawk Box' to discuss the company's quarterly earnings results, which reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes treatment, Mounjaro.

Persons: Geoff Meacham, Eli Lilly Organizations: Bank of America Securities

☆ Elanco's $1.3 billion deal may give the animal health company more flexibility as product launches ramp up
▼ + stars: | 2024-02-06 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +6 min

Elanco Animal Health's decision to sell its aqua division will narrow its focus on pet health and livestock sustainability, as management prepares to launch several new products this year. ELAN 1Y mountain Elanco stock over the past year. One area it identified is pet health, a $15 billion market that has benefited from increasing pet ownership, especially among people who see their pets as family and value their animals' health care. 'Flexibility' to invest behind launches The product launches will also give Elanco a chance to prove itself. The pet health business is very competitive and, once approved, Zenrelia will compete directly with rival Zoetis' Apoquel.

Persons: Elanco, Jeff Simmons, Simmons, Credelio, Cornell University's Richard P, FactSet, Chris Schott, ELAN, Schott, Jefferies, Glen Santangelo, Eli Lilly, Jasper Hellweg, Hellweg, Zenrelia, Zoetis, — CNBC's Michael Bloom Organizations: Merck, CNBC, ELAN, Riney Canine Health, JPMorgan, Argus Locations: U.S

☆ Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
▼ + stars: | 2024-02-06 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Eli Lilly on Tuesday said its highly popular drug used for weight loss and diabetes showed promise as a treatment for fatty liver disease in a mid-stage trial. The condition is characterized by excess fat build-up and inflammation in the liver and can lead to liver scarring, also known as fibrosis. The trial followed around 190 adults with MASH with severe stages of liver scarring, Eli Lilly executives said on an earnings call Tuesday. It was less clear how much the drug reduced liver scarring, which was the second aim of the trial. Eli Lilly is "equally encouraged" by tirzepatide's results in reducing liver scarring, the company's chief scientific officer Dan Skovronsky said on the call.

Persons: Eli Lilly’s, Eli Lilly, tirzepatide, Dan Skovronsky, David Risinger, Eli Lilly's Organizations: Leerink, Novo Nordisk Locations: New York City, U.S

☆ Eli Lilly hits record high: Here's what investors need to know
▼ + stars: | 2024-02-06 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEli Lilly hits record high: Here's what investors need to knowJared Holz, Mizuho Securities healthcare strategist, joins 'Squawk on the Street' to discuss why supply imbalances could boost Eli Lilly's future earnings reports, if clients are asking about the company's valuation, and if there will be capacity constraints coming for healthcare companies.

Persons: Eli Lilly, Jared Holz, Eli Lilly's Organizations: Mizuho Securities Locations: Mizuho

☆ Jim Cramer says the stock market rally has stalled because of two important reasons
▼ + stars: | 2024-02-06 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. But Jim Cramer said, "It is not a broadening rally. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street.

Persons: Jim Cramer, Eli Lilly, Lilly, Jim, David Simon, Tim Cook's, We're, Edwards Lifesciences, Jim Cramer's Organizations: CNBC, Broadcom, Nvidia, Micro, New York Community Bancorp, Signature Bank, Silicon Valley Bank, Linde, Club, DuPont, Air Products, Chemicals, Simon Property, GE Healthcare, Technology, Apple, Vision, Ford, Motors, Tesla, Enphase Energy, CVS Health, Yum Brands, Disney, Wynn Resorts, Jim Cramer's Charitable Locations: We're, New York, Silicon, China, Amgen

☆ We're raising our price target on Eli Lilly by $120 after its excellent quarter
▼ + stars: | 2024-02-06 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +10 min

Bottom line Eli Lilly delivered a strong report Tuesday. Still, it's not a surprise to see shares of Eli Lilly fall nearly 2% Tuesday, to around $694 each. Despite doubling manufacturing capacity year over year in 2023, Eli Lilly said demand for its GLP-1s is "likely to outpace supply" this year. We're raising our Eli Lilly price target to $750 a share from $630, while reiterating our 2 rating on the stock, meaning we'd wait for a pullback before adding to our position. Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023.

Persons: Eli Lilly's, Lilly's, Eli Lilly, Mounjaro, Zepbound, it's, —, Jim Cramer, Anat Ashkenazi, NASH, Lilly, Jim, Jardiance, Verzenio, Trulicity, donanemab, Ashkenazi, Jim Cramer's, George Frey Organizations: Revenue, LSEG, U.S, Novo Nordisk, Food and Drug Administration, Analysts, Investors, FDA, CNBC, Bloomberg, Getty Locations: Mounjaro's, U.S, Mounjaro, Trulicity, Provo , Utah

Search resuls for: "Eli Lilly

25 mentions found